Literature DB >> 25915077

Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial.

Aysel Vehapoglu, Feyza Ustabas, Tolga I Ozgen, Sule Terzioglu, Banu B Cermik, Omer F Ozen.   

Abstract

OBJECTIVES: To investigate serum concentrations of vaspin, apelin, and visfatin in underweight children and their association with anthropometric and nutritional markers of malnutrition. SUBJECTS AND METHODS: We recruited 44 underweight prepubertal children (youngest age = 2 years) with thinness grades of 1, 2, and 3, and body weights < 90% of ideal body weight due to loss of appetite and less frequent hunger episodes. Forty-one healthy age- and gender-matched controls were also included in the study. Serum fasting vaspin, apelin, and visfatin concentrations were measured by enzyme immunoassay technique.
RESULTS: Mean vaspin and apelin levels were significantly lower in underweight children compared to controls (vaspin: 0.44 ± 0.18 vs. 0.58 ± 0.35 pg/mL, p = 0.024; apelin: 483.37 ± 333.26 vs. 711.71 ± 616.50 pg/mL, p = 0.041). Visfatin levels were lower in underweight children compared to controls, but the values were not statistically significant (177.81 ± 158.01 vs. 221.15 ± 212.94 pg/mL, p = 0.119).
CONCLUSIONS: In underweight children, decreased vaspin and apelin levels should be considered in the etiology of anorexia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25915077     DOI: 10.1515/jpem-2014-0490

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  6 in total

1.  Study of salivary and serum vaspin and total antioxidants in anorexia nervosa.

Authors:  Elzbieta Paszynska; Marta Tyszkiewicz-Nwafor; Agnieszka Slopien; Monika Dmitrzak-Weglarz; Agata Dutkiewicz; Teresa Grzelak
Journal:  Clin Oral Investig       Date:  2018-02-14       Impact factor: 3.573

2.  Vaspin (but not neuropeptide B or neuropeptide W) as a possible predictor of body weight normalization in anorexia nervosa.

Authors:  Teresa Grzelak; Marta Tyszkiewicz-Nwafor; Agata Dutkiewicz; Aniceta Ada Mikulska; Monika Dmitrzak-Weglarz; Agnieszka Slopien; Krystyna Czyzewska; Elzbieta Paszynska
Journal:  Arch Med Sci       Date:  2018-04-09       Impact factor: 3.318

3.  Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus.

Authors:  Asmaa Abd El Wakeel Elsehmawy; Safinaz Ebrahim El-Toukhy; Nora Mohamed Ahmed Seliem; Rehab Selim Moustafa; Doaa Sayed Mohammed
Journal:  Diabetes Metab Syndr Obes       Date:  2019-03-22       Impact factor: 3.168

4.  Relationships between Body Weight Status and Serum Levels of Adipokine, Myokine and Bone Metabolism Parameters in Healthy Normal Weight and Thin Children.

Authors:  Jadwiga Ambroszkiewicz; Magdalena Chełchowska; Joanna Mazur; Grażyna Rowicka; Joanna Gajewska
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

5.  Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables.

Authors:  Katarzyna Jowik; Monika Dmitrzak-Węglarz; Natalia Pytlińska; Anna Jasińska-Mikołajczyk; Agnieszka Słopień; Marta Tyszkiewicz-Nwafor
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

Review 6.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.